The Nrf2 pathway is reported as a promising therapeutic target against COVID-19, as it and its antioxidant enzyme heme oxygenase-1 (HO-1) inhibit inflammatory regulatory pathways such as NF-κB [98]. The gene discussed is HMOX1; the disease is COVID-19.